Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study

References

• American College of Rheumatology. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608.
   PubMedGoogle Scholar
• Unterman A, Nolte JES, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011;41(1):1–11.
   PubMed Web of Science ®Google Scholar
• Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC. Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum. 2012;41(6):830–9.
   PubMed Web of Science ®Google Scholar
• Jonsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology. 2002;41(11):1308–12.
   PubMed Web of Science ®Google Scholar
• Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology. 2004;43(12):1555–60.
   PubMed Web of Science ®Google Scholar
• Zirkzee EJM, Huizinga TWJ, Bollen E, Buchem MV, Middelkoop HAM, Wee NVD, et al. Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus. 2014;23(1):31–8.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–91.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang Y, Zhu R, Tian X, Xu D, Wang Q. Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine. 2015;94(17):e794.
   PubMed Web of Science ®Google Scholar
• Ahn GY, Kim D, Won S, Song ST, Jeong HJ, Sohn IW, et al. Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study. Lupus. 2018;27(8):1338–47.
   PubMed Web of Science ®Google Scholar
• Lee YH, Choi SJ, Ji JD, Song GG. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus. 2016;25(7):727–34.
   PubMed Web of Science ®Google Scholar
• Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(2):208–19.
   PubMed Web of Science ®Google Scholar
• Singh AG, Singh S, Matteson EL. Rate risk factors and causes of mortality in patients with Sjögren’s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology. 2016;55(3):450–60.
   PubMed Web of Science ®Google Scholar
• Xue Z, Wang XZ, Liu F, Hu S, Zhu S, Zhang S, et al. Intracranial hypertension syndrome in systemic lupus erythematosus: clinical analysis and review of the literature. J Huazhong Univ Sci Technolog Med Sci. 2009;29(1):107–11.
   PubMedGoogle Scholar
• Maldonado ME, Willianms RC, Adair JC, Hart BL, Gregg L. Neuropsychiatric systemic lupus erythematosus presenting as amyotrophic lateral sclerosis. J Rheumatol. 2002;29(3):633–5.
   PubMed Web of Science ®Google Scholar
• Bertsias G, Ioannidis JP, Aringer M, Bollen EL, Bombardieri S, Bruce IN, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69(12):2074–82.
   PubMed Web of Science ®Google Scholar
• Tokano Y, Morimoto S, Amano H, Kawanishi T, Yano T, Tomyo M, et al. The relationship between initial clinical manifestation and long-term prognosis of patients with systemic lupus erythematosus. Mod Rheumatol. 2005;15(4):275–82.
   PubMedGoogle Scholar
• Dima A, Opris D, Jurcut C, Baicus C. Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus? Lupus. 2016;25(11):1173–9.
   PubMed Web of Science ®Google Scholar
• Gheita TA, El-Gazzar II, Azkalany G, El-Fishawy HS, El-Faramawy A. High-sensitivity c-reactive protein (hs-crp) in systemic lupus erythematosus patients without cardiac involvement; relation to disease activity, damage and intima-media thickness. Egypt Rheumatol. 2012;34(4):147–52.
   Google Scholar
• Hirohata S, Sakuma Y, Yanagida T, Yoshio T. Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus. Arthritis Res Ther. 2014;16:450.
   PubMed Web of Science ®Google Scholar
• Hirohata S, Arinuma Y, Yanagida T, Yoshio T. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther. 2014;16(2):R77.
   PubMed Web of Science ®Google Scholar
• Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol. 2014;10(10):579–96.
   PubMed Web of Science ®Google Scholar
• Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA, Sanna G. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. J Neurol. 2014;261(9):1706–14.
   PubMed Web of Science ®Google Scholar
• Stock AD, Wen J, Putterman C. Neuropsychiatric lupus, the blood brain barrier, and the TWEAK/Fn14 pathway. Front Immunol. 2013;4:484.
   PubMed Web of Science ®Google Scholar